These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 32062570

  • 1. The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma.
    Jo O, Schlicht S, Slavin J, Di Bella C, Pang G, Powell G, Spelman T, Choong PF.
    Eur J Radiol; 2020 Apr; 125():108846. PubMed ID: 32062570
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of Tc-99m (V) DMSA for chondrogenic tumors with positive Tc-99m HMDP uptake on bone scintigraphy.
    Kobayashi H, Kotoura Y, Hosono M, Sakahara H, Hosono M, Yao ZS, Tsuboyama T, Yamamuro T, Endo K, Konishi J.
    Clin Nucl Med; 1995 Apr; 20(4):361-4. PubMed ID: 7788996
    [Abstract] [Full Text] [Related]

  • 3. Tumor grade-related thallium-201 uptake in chondrosarcomas.
    Kaya GC, Demir Y, Ozkal S, Sengoz T, Manisali M, Baran O, Koc M, Tuna B, Ozaksoy D, Havitcioglu H.
    Ann Nucl Med; 2010 May; 24(4):279-86. PubMed ID: 20238186
    [Abstract] [Full Text] [Related]

  • 4. Characterization of cartilaginous tumors with 201Tl scintigraphy.
    Higuchi T, Taki J, Sumiya H, Kinuya S, Nakajima K, Namura M, Tonami N.
    Ann Nucl Med; 2005 Apr; 19(2):95-9. PubMed ID: 15909488
    [Abstract] [Full Text] [Related]

  • 5. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
    Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, Tamura M, Endo K.
    J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
    [Abstract] [Full Text] [Related]

  • 6. Both a visual and a semiquantitative analysis for differentiating benign from malignant chondrogenic bone tumors using Tc-99m (V) DMSA scintigraphy: a prospective study.
    Shinya T, Sato S, Kunisada T, Inai R, Yanai H, Ozaki T, Kanazawa S.
    Nucl Med Commun; 2015 Aug; 36(8):802-7. PubMed ID: 25932541
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic accuracy of functional imaging modalities for chondrosarcoma: A systematic review and meta-analysis.
    Jo I, Gould D, Schlicht S, Taubman K, Choong P.
    J Bone Oncol; 2019 Dec; 19():100262. PubMed ID: 31667063
    [Abstract] [Full Text] [Related]

  • 8. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas?
    Douis H, Parry M, Vaiyapuri S, Davies AM.
    Eur Radiol; 2018 Jan; 28(1):398-409. PubMed ID: 28695356
    [Abstract] [Full Text] [Related]

  • 9. Radiographic Enchondroma Surveillance: Assessing Clinical Outcomes and Costs Effectiveness.
    Akoh CC, Craig E, Troester AM, Miller BJ.
    Iowa Orthop J; 2019 Jan; 39(1):185-193. PubMed ID: 31413693
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions.
    Sahin M, Basoglu T, Bernay I, Yapici O, Canbaz F, Yalin T.
    Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327
    [Abstract] [Full Text] [Related]

  • 11. Chondroid Tumors as Incidental Findings and Differential Diagnosis between Enchondromas and Low-grade Chondrosarcomas.
    Afonso PD, Isaac A, Villagrán JM.
    Semin Musculoskelet Radiol; 2019 Feb; 23(1):3-18. PubMed ID: 30699449
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma.
    Geirnaerdt MJ, Hermans J, Bloem JL, Kroon HM, Pope TL, Taminiau AH, Hogendoorn PC.
    AJR Am J Roentgenol; 1997 Oct; 169(4):1097-104. PubMed ID: 9308471
    [Abstract] [Full Text] [Related]

  • 13. Radiographic differentiation of enchondroma from low-grade chondrosarcoma in the fibula.
    Kendell SD, Collins MS, Adkins MC, Sundaram M, Unni KK.
    Skeletal Radiol; 2004 Aug; 33(8):458-66. PubMed ID: 15221215
    [Abstract] [Full Text] [Related]

  • 14. Low-grade chondrosarcomas: a difficult target for radionuclide imaging. Case report and review of the literature.
    Arsos G, Venizelos I, Karatzas N, Koukoulidis A, Karakatsanis C.
    Eur J Radiol; 2002 Jul; 43(1):66-72. PubMed ID: 12065124
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A retrospective external validation study of the Birmingham Atypical Cartilage Tumour Imaging Protocol (BACTIP) for the management of solitary central cartilage tumours of the proximal humerus and around the knee.
    Van Den Berghe T, Delbare F, Candries E, Lejoly M, Algoet C, Chen M, Laloo F, Huysse WCJ, Creytens D, Verstraete KL.
    Eur Radiol; 2024 Aug; 34(8):4988-5006. PubMed ID: 38319428
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic value and limitations of fluorine-18 fluorodeoxyglucose positron emission tomography for cartilaginous tumors of bone.
    Lee FY, Yu J, Chang SS, Fawwaz R, Parisien MV.
    J Bone Joint Surg Am; 2004 Dec; 86(12):2677-85. PubMed ID: 15590853
    [Abstract] [Full Text] [Related]

  • 19. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors.
    Eefting D, Schrage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovée JV, Hogendoorn PC, EuroBoNeT consortium.
    Am J Surg Pathol; 2009 Jan; 33(1):50-7. PubMed ID: 18852676
    [Abstract] [Full Text] [Related]

  • 20. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A, Ferone D, Lombardi G, Lastoria S.
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.